交易 | 地址 | 数量 |
---|---|---|
75f6e5...ba159c
|
the-void |
-
6.30555531 LTC
·
443.09 USD
|
75f6e5...ba159c
|
LcNS6c...osnkN3
|
+
6.30555531 LTC
·
443.09 USD
|
75f6e5...ba159c
|
script-3473afc95c450ea42854341b43c4aff9 |
+
0 LTC
·
0.00 USD
|
0c17b8...a605f2
|
LXAm8B...FGxDwD
|
-
0.2693008 LTC
·
18.92 USD
|
0c17b8...a605f2
|
LXAm8B...FGxDwD
|
-
0.2702868 LTC
·
18.99 USD
|
0c17b8...a605f2
|
LXAm8B...FGxDwD
|
-
0.2800528 LTC
·
19.67 USD
|
0c17b8...a605f2
|
LXAm8B...FGxDwD
|
-
0.2667748 LTC
·
18.74 USD
|
0c17b8...a605f2
|
LXAm8B...FGxDwD
|
-
0.5349006 LTC
·
37.58 USD
|
0c17b8...a605f2
|
LXAm8B...FGxDwD
|
-
0.2702558 LTC
·
18.99 USD
|
0c17b8...a605f2
|
LXAm8B...FGxDwD
|
-
0.5548626 LTC
·
38.99 USD
|
MEI Pharma's stock surged over 33%, raising its market cap to $41.24 million. A strategic transformation led by Titan Partners Group and GSR is pushing MEI Pharma to establish a Litecoin treasury strategy.